Vincent Meunier

Stock Analyst at Morgan Stanley

(1.04)

# 3,616

Out of 4,854 analysts

9

Total ratings

33.33%

Success rate

-4.48%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Vincent Meunier

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVS Novartis AG	Upgrades: Equal-Weight	n/a	$118.02	-	7	Sep 25, 2023
	NVO Novo Nordisk	Initiates: Equal-Weight	n/a	$74.63	-	2	Dec 14, 2018

Novartis AG

Sep 25, 2023

Upgrades: Equal-Weight

Price Target: n/a

Current: $118.02

Upside: -

Novo Nordisk

Dec 14, 2018

Initiates: Equal-Weight

Price Target: n/a

Current: $74.63

Upside: -